&nbsp; <P>&nbsp;</P> <P align=justify><STRONG>Lyon is strengthening its research pole in the <STRONG><A style="COLOR: #e02020" title="" href="https://www.aderly.com/pharmaceutique_biotech/index,p,100044,EN.jsp" target=_blank>neurosciences field</A><A href="https://www.aderly.com/pharmaceutique_biotech/index,p,100044,EN.jsp"></STRONG></A><A style="COLOR: #e02020" title="" href="https://www.aderly.com/pharmaceutique_biotech/index,p,100044,EN.jsp" target=_blank> </A></STRONG>by inaugurating in early October its neurosciences research center. Officially created in January 2011, the center is located in a 5,600sq.m building called Neurocampus. 11 teams from the <A style="COLOR: #e02020" title="" href="http://www.univ-lyon1.fr/recherche/" target=_blank>Claude Bernard University of Lyon 1</A>, the <A style="COLOR: #e02020" title="" href="http://www.alpes.cnrs.fr/" target=_blank>National Scientific Research Center </A>(CNRS) and the <A style="COLOR: #e02020" title="" href="http://www.inserm.fr/" target=_blank>National Institute for Health and Medical Research </A>(INSERM) are based there.</P> <P align=justify>&nbsp;<BR><STRONG>The center will house approximately 350 scientists and provide them access to state-of-the-art technical investigation platforms, in the hopes of developing new therapies.</STRONG> In 2013, Neurocampus will acquire a hybrid IRM-TEP machine that combines some images by magnetic resonance and others by positon emissions. Today, there are 15 machines like this in the world, and the Center&#8217;s will be the first in France.</P> <P align=justify><BR></P>